TOG Review (RCOG Journal)

MRCOG Part 2

Gynaecological Oncology

Hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of ovarian cancer

Key Statistics

  • 14.2 vs 10.7 mo — OVHIPEC PFS (HIPEC vs CRS)
  • 45.7 vs 33.9 mo — OVHIPEC OS (HIPEC vs CRS)
  • 100 mg/m² — Cisplatin dose, 40°c, 90 min

Don't-miss facts

  1. HIPEC = adjuvant only; surgery to NMRD remains the key determinant of outcome

  2. OVHIPEC protocol: cisplatin 100 mg/m² at 40°C for 90 minutes, at interval CRS → PFS 14.2 vs 10.7 mo, OS 45.7 vs 33.9 mo

  3. Sodium thiosulphate nephroprotection: 9 g/m² bolus then 12 g/m² over 6 hours before cisplatin

  4. HIPEC only proceeds if residual disease ≤2.5 mm after interval CRS; adds ~2 hours theatre time

  5. No proven benefit at primary surgery or recurrence – OVHIPEC-2 result awaited (2026)

  6. ASA ≤2 required for HIPEC consideration in real-world practice; no significant difference in grade 3/4 complications vs CRS alone

  7. NICE IPG688: HIPEC delivery restricted to specialised, trained centres with governance and audit

  8. Greatest benefit seen in high-grade serous, HRD/BRCA wild-type tumours

Guideline positions at a glance

NCCN/NICE: HIPEC can be considered at interval CRS, specialised centres ESGO: RCTs only · BGCS: no recommendation

Abbreviation Key

  • HIPEC — hyperthermic intraperitoneal chemotherapy
  • HRD — homologous recombination deficiency
  • IP — intraperitoneal
  • BRCA — breast cancer gene
  • IV — intravenous
  • PARP — poly ADP-ribose polymerase
  • CRS — cytoreductive surgery
  • NCCN — National Comprehensive Cancer Network
  • NMRD — nil macroscopic residual disease
  • NICE — National Institute for Health and Care Excellence
  • PFS — progression-free survival
  • ESGO — European Society of Gynaecological Oncology
  • OS — overall survival
  • BGCS — British Gynaecological Cancer Society
  • RCT — randomised controlled trial EORTC
  • QLQ-C30 — European Organisation for Research and Treatment of Cancer core quality-of-life questionnaire
  • FIGO — International Federation of Gynecology and Obstetrics
  • HRQoL — health-related quality of life
  • ASA — American Society of Anaesthesiologists
  • MDT — multidisciplinary team
  • ERAS — enhanced recovery after surgery

Source: Graham R et al. Hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of ovarian cancer. The Obstetrician & Gynaecologist 2024;26:76–83. doi:10.1111/tog.12916

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free